Zimmer Biomet Holdings Inc (NYSE: ZBH) on Tuesday, soared 1.13% from the previous trading day, before settling in for the closing price of $106.85. Within the past 52 weeks, ZBH’s price has moved between $101.47 and $133.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -1.20% annually for the last half of the decade. The company achieved an average annual earnings per share of 5.76%. With a float of $198.79 million, this company’s outstanding shares have now reached $199.60 million.
In an organization with 18000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 66.29%, operating margin of 18.12%, and the pretax margin is 13.59%.
Zimmer Biomet Holdings Inc (ZBH) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Zimmer Biomet Holdings Inc is 0.14%, while institutional ownership is 92.83%. The most recent insider transaction that took place on May 31 ’24, was worth 1,474,582. In this transaction Group President, Asia Pacific of this company sold 12,857 shares at a rate of $114.69, taking the stock ownership to the 5,322 shares. Before that another transaction happened on Mar 07 ’24, when Company’s Group President, Asia Pacific sold 1,705 for $126.86, making the entire transaction worth $216,296. This insider now owns 18,179 shares in total.
Zimmer Biomet Holdings Inc (ZBH) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 5.76% per share during the next fiscal year.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Trading Performance Indicators
Zimmer Biomet Holdings Inc (ZBH) is currently performing well based on its current performance indicators. A quick ratio of 0.70 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.83. Likewise, its price to free cash flow for the trailing twelve months is 19.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.25, a number that is poised to hit 2.30 in the next quarter and is forecasted to reach 8.58 in one year’s time.
Technical Analysis of Zimmer Biomet Holdings Inc (ZBH)
Let’s dig in a bit further. During the last 5-days, its volume was 1.52 million. That was better than the volume of 1.49 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 28.37%. Additionally, its Average True Range was 2.28.
During the past 100 days, Zimmer Biomet Holdings Inc’s (ZBH) raw stochastic average was set at 43.24%, which indicates a significant increase from 37.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 14.68% in the past 14 days, which was lower than the 24.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $107.69, while its 200-day Moving Average is $113.06. However, in the short run, Zimmer Biomet Holdings Inc’s stock first resistance to watch stands at $109.98. Second resistance stands at $111.89. The third major resistance level sits at $113.34. If the price goes on to break the first support level at $106.62, it is likely to go to the next support level at $105.17. Assuming the price breaks the second support level, the third support level stands at $103.26.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Key Stats
Market capitalization of the company is 21.51 billion based on 199,074K outstanding shares. Right now, sales total 7,394 M and income totals 1,024 M. The company made 1,824 M in profit during its latest quarter, and 249,000 K in sales during its previous quarter.
